COMPARISON OF SWITCHING TO REDUCED DOSE VS CONTINUATION OF STANDARD DOSE ETANERCEPT FOR RHEUMATOID ARTHRITIS PATIENTS IN THE CORRONA REGISTRY

被引：2
|
作者：
Greenberg, J. D. [1 ,2 ]
Shan, Y. [2 ]
Reed, G. W. [2 ,3 ]
Bitman, B. [4 ]
Collier, D. [5 ]
机构：
[1] NYU, Sch Med, New York, NY USA
[2] CORRONA Inc, Southborough, MA USA
[3] Univ Massachusetts, Sch Med, Worcestesr, MA USA
[4] Amgen Inc, San Francisco, CA USA
[5] Amgen Inc, Thousand Oaks, CA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.1836
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0174
引用
收藏
页码：241 / 241
页数：1
相关论文
共 50 条
  • [1] Full dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis
    van Vollenhoven, Ronald F.
    Ostergaard, Mikkel
    Leirisalo-Repo, Marjatta
    Uhlig, Till
    Jansson, Marita
    Larsson, Esbjorn
    Brock, Fiona
    Franck-Larsson, Karin
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (01) : 52 - 58
  • [2] Infliximab, Etanercept, and Adalimumab switching in patients with rheumatoid arthritis in the CORRONA database
    Dabbous, O.
    Kremer, J.
    Rambharose, J.
    El Taha, M.
    Reed, G.
    Tang, B.
    Thomson, H.
    Domdey, A.
    Rahman, M.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2008, 37 : 42 - 42
  • [3] Effects of high-dose etanercept patients with rheumatoid arthritis (RA) with partial responses to standard-dose etanercept
    Goldman, A
    Solinger, A
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 276 - 277
  • [4] COMPARISON OF EFFECTS OF STANDARD- AND LOW-DOSE ETANERCEPT ON INFLAMMATORY SYNOVITIS IN RHEUMATOID ARTHRITIS PATIENTS AS ASSESSED BY ULTRASONOGRAPHY
    Mamoto, K.
    Koike, T.
    Okano, T.
    Sugioka, Y.
    Tada, M.
    Inui, K.
    Nakamura, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 1010 - 1011
  • [5] Comparison Of Effects Of Standard- and Low-Dose Etanercept On Inflammatory Synovitis In Rheumatoid Arthritis Patients As Assessed By Ultrasonography
    Mamoto, Kenji
    Koike, Tatsuya
    Okano, Tadashi
    Sugioka, Yuko
    Tada, Masahiro
    Inui, Kentaro
    Nakamura, Hiroaki
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S615 - S615
  • [6] Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
    Rosalía Martínez-Pérez
    Sergio Rodríguez-Montero
    Alejandro Muñoz
    Julia Uceda
    Mario León
    Francisco Gallo
    Maria Luisa Velloso
    José Luis Marenco
    Journal of Translational Medicine, 9 (Suppl 2)
  • [7] Optimal dose of etanercept in the treatment of rheumatoid arthritis
    Curtis, Elizabeth Mary
    Marks, Jonathan Lewis
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2014, 6 : 27 - 38
  • [8] Prevention of Cartilage Destruction by Etanercept (PRECEPT) Study: the Comparison of Joint Destruction Between Low-Dose and Standard-Dose Etanercept in Rheumatoid Arthritis.
    Tada, Masahiro
    Okano, Tadashi
    Sugioka, Yuko
    Mamoto, Kenji
    Wakitani, Shigeyuki
    Nakamura, Hiroaki
    Koike, Tatsuya
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S151 - S152
  • [9] Immunogenicity and Safety of High Dose vs. Standard Dose of inactivated Influenza Vaccine in Patients with rheumatoid Arthritis
    Christenn, Michaela
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2021, 80 (08): : 756 - 757
  • [10] Drug Survival and Long-Term Dose Comparison of Etanercept and Infliximab in Rheumatoid Arthritis Patients
    Hanna, Brian D.
    Shah, Alpesh
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S477 - S477
12345